- Home
- NKLA vs APLT Comparison
NKLA vs APLT Comparison
Compare NKLA & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKLA
- APLT
- Stock Information
- Founded
- NKLA 2015
- APLT 2016
- Country
- NKLA United States
- APLT United States
- Employees
- NKLA N/A
- APLT N/A
- Industry
- NKLA Auto Manufacturing
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- NKLA Consumer Discretionary
- APLT Health Care
- Exchange
- NKLA Nasdaq
- APLT Nasdaq
- Market Cap
- NKLA 98.8M
- APLT 80.3M
- IPO Year
- NKLA N/A
- APLT 2019
- Fundamental
- Price
- NKLA $0.38
- APLT $0.53
- Analyst Decision
- NKLA Hold
- APLT Buy
- Analyst Count
- NKLA 4
- APLT 7
- Target Price
- NKLA $6.00
- APLT $6.10
- AVG Volume (30 Days)
- NKLA 30.1M
- APLT 2.9M
- Earning Date
- NKLA 03-04-2025
- APLT 03-05-2025
- Dividend Yield
- NKLA N/A
- APLT N/A
- EPS Growth
- NKLA N/A
- APLT N/A
- EPS
- NKLA N/A
- APLT N/A
- Revenue
- NKLA $75,529,000.00
- APLT N/A
- Revenue This Year
- NKLA $215.41
- APLT N/A
- Revenue Next Year
- NKLA $167.59
- APLT $2,622.90
- P/E Ratio
- NKLA N/A
- APLT N/A
- Revenue Growth
- NKLA 153.71
- APLT N/A
- 52 Week Low
- NKLA $0.35
- APLT $0.53
- 52 Week High
- NKLA $34.50
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- NKLA 34.43
- APLT 29.75
- Support Level
- NKLA $0.35
- APLT $0.54
- Resistance Level
- NKLA $0.53
- APLT $0.70
- Average True Range (ATR)
- NKLA 0.12
- APLT 0.06
- MACD
- NKLA -0.00
- APLT 0.06
- Stochastic Oscillator
- NKLA 5.73
- APLT 0.00
About NKLA Nikola Corporation
Nikola Corp is a technology innovator and integrator, working to develop inventive energy and transportation solutions. It works on a business model that enables customers and fleets to integrate next-generation truck technology, hydrogen fueling and charging infrastructure, and related maintenance. It operates in two business units: Truck and Energy. The Truck business unit and Energy business unit. The Truck business unit is engaged manufacturing and selling FCEV and BEV trucks that provide, environmentally friendly, cost effective solutions to the trucking sector. The Energy business unit is engaged in developing and constructing a network of hydrogen fueling stations to meet hydrogen fuel demand for the Company's customers.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.